| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 211.26B | 189.42B | 165.51B | 183.22B | 163.67B |
| Gross Profit | 89.00B | 85.37B | 72.50B | 88.19B | 74.94B |
| EBITDA | 62.75B | 64.97B | 55.70B | 65.64B | 59.56B |
| Net Income | 33.14B | 33.03B | 26.48B | 34.65B | 31.44B |
Balance Sheet | |||||
| Total Assets | 431.18B | 416.87B | 403.45B | 401.36B | 394.78B |
| Cash, Cash Equivalents and Short-Term Investments | 87.33B | 85.67B | 90.34B | 88.03B | 68.39B |
| Total Debt | 6.22B | 5.20B | 5.93B | 5.48B | 4.97B |
| Total Liabilities | 53.10B | 45.90B | 38.76B | 50.97B | 52.15B |
| Stockholders Equity | 378.07B | 370.15B | 364.17B | 349.85B | 342.07B |
Cash Flow | |||||
| Free Cash Flow | 25.86B | 29.00B | 8.98B | 27.14B | 30.47B |
| Operating Cash Flow | 45.88B | 55.68B | 41.05B | 45.65B | 44.32B |
| Investing Cash Flow | -9.25B | -42.95B | -13.94B | 6.40B | -10.88B |
| Financing Cash Flow | -37.92B | -16.67B | -28.19B | -34.17B | -25.25B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥812.88B | 27.76 | 8.07% | 2.85% | 11.53% | 1.60% | |
71 Outperform | ¥119.12B | 31.61 | ― | 2.20% | 8.69% | 74.50% | |
70 Outperform | ¥14.42T | 72.11 | 8.95% | 1.88% | 5.02% | 2.02% | |
67 Neutral | ¥6.85T | 39.58 | ― | 1.41% | 13.61% | 17.01% | |
66 Neutral | ¥433.32B | 15.41 | 11.96% | 3.04% | 2.93% | -26.76% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
55 Neutral | ¥169.18B | 24.16 | 5.91% | 2.39% | 2.81% | -39.05% |